Effects of HQK-1001 in Patients With Sickle Cell Disease
Public ClinicalTrials.gov record NCT01601340. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Placebo-controlled, Phase 2 Study of HQK-1001 in Sickle Cell Disease
Study identification
- NCT ID
- NCT01601340
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- HemaQuest Pharmaceuticals Inc.
- Industry
- Enrollment
- 77 participants
Conditions and interventions
Conditions
Interventions
- HQK-1001 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2012
- Primary completion
- Oct 31, 2013
- Completion
- Nov 30, 2013
- Last update posted
- Mar 17, 2015
2012 – 2013
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of South Alabama | Mobile | Alabama | 36617-2238 | — |
| Children's Hospital and Research Center - Oakland | Oakland | California | 94609 | — |
| Children's National Hospital | Washington D.C. | District of Columbia | 20010 | — |
| Howard University Hospital | Washington D.C. | District of Columbia | 20060 | — |
| Georgia Health Sciences University | Augusta | Georgia | 30912 | — |
| University of Illinois at Chicago | Chicago | Illinois | 60612 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| New York Methodist Hospital | Brooklyn | New York | 11215 | — |
| The Children's Hospital at Montefiore Medical Center | The Bronx | New York | 10467 | — |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| Virginia Commonwealth Univeristy - Center on Health Disparities | Richmond | Virginia | 23298 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01601340, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 17, 2015 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01601340 live on ClinicalTrials.gov.